Etalocib, formerly known as LY293111 and VML295, is a novel diaryl ether carboxylic acid analogue, is a potent and selective inhibitor of the lipoxygenase pathway either directly through 5'-lipoxygenase or via antagonism of the leukotriene B4 (LTB4) receptor. LY293111 has antineoplastic activity in a variety of preclinical models.

纯度：≥98%

CAS：161172-51-6